INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
SEC FORM 4/Grant or awardVerified data

Ward Peter reported LAES

Director · SEALSQ Corp · SEALSQ Corp — Employee Stock Option Plan (right to buy)

Side
A
Value
—
Shares
3,582
Price
—
Executed
Oct 5, 2026
Disclosed
Oct 6, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Oct 5 executedOct 6, 2026 disclosed

LAES · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · LAES

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    7
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Option exercise · 10b5-1 plan
    		M$200
    20.0K sh
    		Nov 2, 2026Nov 3, 2026
    traded Nov 2, 2026
    		+1dSEC FORM 4

    Evidence

    0
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Grant or award · 10b5-1 plan
    		A—
    50.0K sh
    		Nov 2, 2026Nov 3, 2026
    traded Nov 2, 2026
    		+1dSEC FORM 4

    Evidence

    7
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Option exercise · 10b5-1 plan
    		M—
    20.0K sh
    		Nov 2, 2026Nov 3, 2026
    traded Nov 2, 2026
    		+1dSEC FORM 4

    Evidence

    13
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Open-market sale · 10b5-1 plan
    		SELL$48K
    35.0K sh
    		Nov 3, 2026Nov 3, 2026
    traded Nov 3, 2026
    		+0dSEC FORM 4

    Evidence

    0
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Option exercise · 10b5-1 plan
    		M$150
    15.0K sh
    		Nov 2, 2026Nov 3, 2026
    traded Nov 2, 2026
    		+1dSEC FORM 4

    Evidence

    0
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Option exercise · 10b5-1 plan
    		M—
    15.0K sh
    		Nov 2, 2026Nov 3, 2026
    traded Nov 2, 2026
    		+1dSEC FORM 4

    Evidence

    0
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Option exercise · 10b5-1 plan
    		M—
    35.0K sh
    		Oct 5, 2026Oct 7, 2026
    traded Oct 5, 2026
    		+2dSEC FORM 4

    Evidence

    16
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Open-market sale · 10b5-1 plan
    		SELL$86K
    35.0K sh
    		Oct 6, 2026Oct 7, 2026
    traded Oct 6, 2026
    		+1dSEC FORM 4

    Evidence

    0
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Grant or award · 10b5-1 plan
    		A—
    50.0K sh
    		Oct 5, 2026Oct 7, 2026
    traded Oct 5, 2026
    		+2dSEC FORM 4

    Evidence

    0
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Option exercise · 10b5-1 plan
    		M$350
    35.0K sh
    		Oct 5, 2026Oct 7, 2026
    traded Oct 5, 2026
    		+2dSEC FORM 4

    Evidence

    19
    FA
    Fergusson David AlexanderDirector
    LAESSEALSQ Corp
    Grant or award
    		A—
    14.1K sh
    		Sep 25, 2026Oct 6, 2026
    traded Sep 25, 2026
    		+11dSEC FORM 4

    Evidence

    19
    FA
    Fergusson David AlexanderDirector
    LAESSEALSQ Corp
    Grant or award
    		A—
    3,424 sh
    		Sep 25, 2026Oct 6, 2026
    traded Sep 25, 2026
    		+11dSEC FORM 4

    Evidence

    19
    PA
    Pellaton Eric AdrienDirector
    LAESSEALSQ Corp
    Grant or award
    		A—
    10.7K sh
    		Sep 25, 2026Oct 6, 2026
    traded Sep 25, 2026
    		+11dSEC FORM 4

    Evidence

    19
    PA
    Pellaton Eric AdrienDirector
    LAESSEALSQ Corp
    Grant or award
    		A—
    14.1K sh
    		Sep 25, 2026Oct 6, 2026
    traded Sep 25, 2026
    		+11dSEC FORM 4

    Evidence

    9
    WP
    Ward PeterDirector
    LAESSEALSQ Corp
    Grant or award
    		A—
    4,686 sh
    		Oct 5, 2026Oct 6, 2026
    traded Oct 5, 2026
    		+1dSEC FORM 4

    Evidence

    0
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Option exercise · 10b5-1 plan
    		M$150
    15.0K sh
    		Sep 1, 2026Sep 3, 2026
    traded Sep 1, 2026
    		+2dSEC FORM 4

    Evidence

    13
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Open-market sale · 10b5-1 plan
    		SELL$36K
    15.0K sh
    		Sep 3, 2026Sep 3, 2026
    traded Sep 3, 2026
    		+0dSEC FORM 4

    Evidence

    0
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Option exercise · 10b5-1 plan
    		M—
    15.0K sh
    		Sep 1, 2026Sep 3, 2026
    traded Sep 1, 2026
    		+2dSEC FORM 4

    Evidence

    9
    WP
    Ward PeterDirector
    LAESSEALSQ Corp
    Option exercise
    		M—
    353.1K sh
    		Jun 16, 2026Jun 18, 2026
    traded Jun 16, 2026
    		+2dSEC FORM 4

    Evidence

    27
    WP
    Ward PeterDirector
    LAESSEALSQ Corp
    Tax withholding
    		F$296K
    96.5K sh
    		Jun 16, 2026Jun 18, 2026
    traded Jun 16, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001896009-26-000008
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Oct 5, 2026
    Published
    Oct 6, 2026
    Ingested by INSIDER
    Nov 5, 02:13 UTC
    Last re-read
    Nov 5, 02:13 UTC

    Extracted facts

    Filer
    Ward Peter
    Role
    Director
    Transaction
    Grant or awardAs filed: “A”
    Asset
    SEALSQ Corp — Employee Stock Option Plan (right to buy)
    Ticker
    LAES
    Shares
    3,582
    Price per share
    $0
    Execution date (reported)
    Oct 5, 2026
    Owned after transaction
    3,582 shares
    Days from execution to publication
    1

    What this establishes

    Ward Peter filed this Form 4 reporting a grant or award of LAES on Oct 5, 2026. It became public on Oct 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Ward Petercik:0001896009
    Issuer
    SEALSQ Corpcik:0001951222

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.